Ramazan Gundogdu

5PUBLICATIONS
15CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)NaturopathyCheminformatics and quantitative structure-activity relationshipsMolecular medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Mar 28, 2026
MOB2 Loss Sensitizes Lung Cancer Cells to PARP Inhibition Through p53-Dependent DNA Damage Signaling.

Ramazan Gundogdu

|Jan 10, 2026
Resveratrol potentiates chemotherapeutic efficacy of olaparib in MCF7 human breast cancer cells by inducing apoptosis.

Mehmet Kadir Erdoğan, Ramazan Gundogdu, Yusuf Toy

|Dec 05, 2024
Verbascum gimgimense an Endemic Turkish Plant: Evaluation of In Vitro Anticancer, Antioxidant, Enzyme Inhibitory Activities, and Phytochemical Profile.

Mehmet Kadir Erdogan, Aydın Sever, Ramazan Gundogdu

|Jan 13, 2023
In vitro anticancer, antioxidant and enzyme inhibitory potentials of endemic Cephalaria elazigensis var. purpurea with in silico studies.

Mehmet Kadir Erdogan, Ramazan Gundogdu, Yakup Yapar

|Dec 15, 2022
Royal jelly arranges apoptotic and oxidative stress pathways and reduces damage to liver tissues of rats by down-regulation of Bcl-2, GSK3 and NF-κB and up-regulation of caspase and Nrf-2 protein signalling pathways.

Abdullah Aslan, Ozlem Gok, Seda Beyaz

Pageof 1

Frequent Collaborators

3 joint publications

Mehmet Kadir Erdogan

2 joint publications

Yakup Yapar

2 joint publications

Ibrahim Halil Gecibesler

2 joint publications

Lutfi Behcet